# CRA International, Inc. (CRAI)

> Source: Nexqual · https://nexqual.com/CRAI · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, CRA International, Inc. (CRAI), nexqual.com/CRAI" · informational, not investment advice.

**Price:** USD 200.14 (-0.40% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 200.94 · day 196.53–202.05 · 52w 132.17–227.29 · market cap $1.26B · NMS

## Key facts
- Last four reported quarters (through Jul 4, 2026): revenue $795M, net income $49.3M (6.2% margin), free cash flow -$27.7M (SEC filings).
- Valuation: P/E 25.5x (avg 23.1x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold CRAI (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (2 analysts), mean target USD 250.5 (range 245–256).
- Total return with dividends: 1Y +7.8% vs S&P 500 +13.4%; 5Y +94.2% vs S&P 500 +76.9%.
- Next earnings: 2026-11-05, EPS estimate USD 2.07, revenue estimate $199M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $566M | $591M | $624M | $687M | $752M | $795M |
| Operating income | $55.7M | $58.7M | $57.5M | $70.8M | $83.1M | $79.4M |
| Net income | $41.7M | $43.6M | $38.5M | $46.7M | $54.8M | $49.3M |
| EPS (diluted) | $5.45 | $5.91 | $5.39 | $6.74 | $8.14 | — |
| Free cash flow | $73.1M | $21.3M | $57.7M | $33.1M | $18.6M | -$27.7M |
| Operating margin | 9.8% | 9.9% | 9.2% | 10.3% | 11.1% | 10.0% |
| Net margin | 7.4% | 7.4% | 6.2% | 6.8% | 7.3% | 6.2% |
| Revenue growth | +11.3% | +4.4% | +5.6% | +10.2% | +9.3% | — |
| Cash + short-term investments | $66.1M | $31.4M | $45.6M | $26.7M | $18.2M | — |
Fiscal years end Jan. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jul 4, 2026)
P/E 25.5x · P/S 1.6x · P/B 6.9x · FCF yield -2.21% · Earnings yield 3.92% · Dividend yield (paid, TTM) 1.15% · Buyback yield (TTM) 4.24%
P/E at fiscal year-ends: Jan 2026 23.2x, Dec 2024 27.7x, Dec 2023 18.3x.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold CRAI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Third Avenue Management |  | 0.47% | $3.0M | New position |

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 2 analysts; mean target USD 250.5 (low 245, high 256).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +7.8% | +94.2% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +7.8% | +14.2% |
| Volatility (annualized) | 39.8% | 34.6% |
| Max drawdown | -38.1% (Jan 2026→May 2026) | -36.2% (Jan 2026→May 2026) |

## Peers (Consulting Services)
ICFI (ICF International, Inc.) USD 94.4 +1.15% · SBC (SBC Medical Group Holdings Inco) USD 5.28 -7.21% · HURN (Huron Consulting Group Inc.) USD 195.69 +1.21% · FCN (FTI Consulting, Inc.) USD 157.24 -0.22% · ROMA (Roma Green Finance Limited) USD 6 -12.08% · BAH (Booz Allen Hamilton Holding Cor) USD 78.32 -0.32%

## More
Full page: https://nexqual.com/CRAI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by region (quarter ended 2026-07-04)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| United States | $165.2M | 78.4% | +8.9% |
| United Kingdom | $30.1M | 14.3% | +34.1% |
| Other | $15.5M | 7.3% | +22.2% |
| Total revenue | $210.8M | 100% | — |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $2.07 | $2.19 | -5.5% | $199.0M | 3 |
| Next quarter (ends 2026-12-31) | $2.24 | $2.27 | -1.2% | $203.5M | 3 |
| Current fiscal year (ends 2026-12-31) | $8.47 | $8.60 | -1.5% | $814.3M | 3 |
| Next fiscal year (ends 2027-12-31) | $9.56 | $9.63 | -0.7% | $847.0M | 3 |